Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eurofins Scientific | Paris | Healthcare | Biotechnology & Medical Research | €10.52B | 33.3x | 0.7 | €54.56 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.3% Downside | Upgrade to Pro+ | |
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €483.39M | -5.4x | 0.03 | €2.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €344.40M | -1.9x | -0.12 | €5.43 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €307.08M | -1x | 0.06 | €3.21 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €253.60M | €25.25 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €190.69M | 127.7x | 1.23 | €3.83 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €179.71M | -3.2x | 0.01 | €1.95 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €160.70M | -2.3x | 0.06 | €3.39 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €134.60M | 3.5x | 0.02 | €6.04 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | €103.91M | €20,600 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €100.66M | -3.7x | -0.09 | €0.34 | -7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | €96.35M | -5.3x | -0.18 | €5.33 | 9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.6% Upside | Upgrade to Pro+ | |
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €94.44M | -2.4x | -0.04 | €1.31 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €83M | -2.7x | 0.11 | €5.20 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transgene | Paris | Healthcare | Biotechnology & Medical Research | €77.31M | -2x | 0.07 | €0.59 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fermentalg | Paris | Healthcare | Biotechnology & Medical Research | €51.91M | -3.5x | -0.08 | €0.59 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.7% Upside | Upgrade to Pro+ | |
Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | €42.58M | -9.4x | 1.15 | €1.23 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | €33.02M | -0.7x | 0.01 | €0.47 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genoway | Paris | Healthcare | Biotechnology & Medical Research | €28.21M | €3.06 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Gensight Biologics | Paris | Healthcare | Biotechnology & Medical Research | €27.32M | -1.4x | -0.03 | €0.21 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Poxel SA | Paris | Healthcare | Biotechnology & Medical Research | €22M | -1x | -0.02 | €0.41 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valbiotis | Paris | Healthcare | Biotechnology & Medical Research | €17.25M | -1.7x | 0.24 | €1.09 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NFL Biosciences | Paris | Healthcare | Biotechnology & Medical Research | €17.11M | -6.4x | -0.13 | €1.64 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | €14.11M | -3x | 0.17 | €3.77 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Plant Advanced Technologies SA | Paris | Healthcare | Biotechnology & Medical Research | €12.28M | -18.7x | €11 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Theranexus | Paris | Healthcare | Biotechnology & Medical Research | €7.18M | -1.1x | €0.93 | 39.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Oncodesign Precision Medicine | Paris | Healthcare | Biotechnology & Medical Research | €6.90M | -0.9x | €0.38 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
TME Pharma NV | Paris | Healthcare | Biotechnology & Medical Research | €6.87M | -0.4x | -0.01 | €0.07 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum Genomics SA | Paris | Healthcare | Biotechnology & Medical Research | €5.03M | -0.5x | -0.01 | €0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.7% Upside | Upgrade to Pro+ | |
Integragen | Paris | Healthcare | Biotechnology & Medical Research | €4.01M | €0.61 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Phaxiam Therapeutics | Paris | Healthcare | Biotechnology & Medical Research | €3.53M | €0.35 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Biophytis SA | Paris | Healthcare | Biotechnology & Medical Research | €3.39M | -0x | -0 | €0.17 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Geneuro | Paris | Healthcare | Biotechnology & Medical Research | €2.07M | -0.2x | €0.07 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Medesis Pharma | Paris | Healthcare | Biotechnology & Medical Research | €1.77M | -0.6x | -0.17 | €0.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coretech 5 | Paris | Healthcare | Biotechnology & Medical Research | €402.20K | -9.6x | €0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Neovacs | Paris | Healthcare | Biotechnology & Medical Research | €13.66K | €0.007 | -17.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |